Preventing Childhood Antibiotic-associated Diarrhea by Prebiotics (WGAAD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00826137|
Recruitment Status : Completed
First Posted : January 21, 2009
Last Update Posted : June 14, 2012
|Condition or disease||Intervention/treatment||Phase|
|Antibiotic-Associated Diarrhea||Dietary Supplement: Inulin and fructo-oligosaccharides. Dietary Supplement: Placebo||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Prebiotics in the Prevention of Antibiotic-associated Diarrhea in Children|
|Study Start Date :||December 2008|
|Primary Completion Date :||December 2009|
|Study Completion Date :||July 2010|
Treated with prebiotics.
Dietary Supplement: Inulin and fructo-oligosaccharides.
Supplement during antibiotic treatment+14 days.
Other Name: Placebo is base powder of product with no oligosaccharides.
Placebo Comparator: B
Dietary Supplement: Placebo
Placebo is base powder of product with no oligosaccharides.
- Prevention of diarrhea. [ Time Frame: During antibiotic treatment+14 days ]
- Duration of diarrhea. [ Time Frame: During antibiotic treatment+14 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00826137
|Soroka Medical Center|
|Beer-Sheva, Israel, 84101|
|Principal Investigator:||Zvi Weizman, MD||Soroka University Medical Center|